Development of an oral nanovaccine for dogs against Echinococcus granulosus

Eur J Pharm Biopharm. 2023 Nov:192:185-195. doi: 10.1016/j.ejpb.2023.09.012. Epub 2023 Sep 26.

Abstract

Dogs are the main source of animal and human cystic echinococcosis caused by the Cestode parasite Echinococcus granulosus. Dog vaccination seems to be a good strategy to control this parasitic disease. Here we present the development of a polymeric nanoparticle-based oral vaccine for dogs against Echinococcus granulosus delivered in enteric-coated capsules. To achieve our target, we encapsulated two recombinant antigens into biodegradable polymeric nanoparticles in the presence of Monophosphoryl lipid A as an adjuvant to ensure efficient delivery and activation of a protective mucosal immune response. The formulated delivery system showed a nanoparticle size less than 200 nm with more than 80 % antigen encapsulation efficiency and conserved integrity and immunogenicity. The nanoparticle surface was coated with chitosan to enhance adhesion to the gut mucosa and a subsequent antigen delivery. Chitosan-coated nanoparticles showed a higher cell internalization in murine macrophages and dendritic cells as well as a higher penetration into Caco-2 cells in vitro. Antigen-loaded nanoparticles were freeze-dried and enteric-coated capsules were filled with the obtained powder. The obtained results show a promising nanoparticles delivery system for oral vaccination.

Keywords: Chitosan; Dog; Echinococcus granulosus; Oral vaccine; Polymeric nanoparticles.

MeSH terms

  • Animals
  • Antigens
  • Caco-2 Cells
  • Chitosan*
  • Dogs
  • Echinococcosis* / parasitology
  • Echinococcosis* / prevention & control
  • Echinococcus granulosus* / physiology
  • Humans
  • Mice
  • Vaccines*

Substances

  • Chitosan
  • Vaccines
  • Antigens